Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: Analytical and clinical validity

Journal of Clinical Microbiology

Volumn 50, Issue 4, 2012, Pages 1258-1263

  D'Haese, Jorien ^a   Theunissen, Koen ^a   Vermeulen, Edith ^a   Schoemans, Hélène ^a   De Vlieger, Greet ^a   Lammertijn, Liesbet ^a   Meersseman, Philippe ^a   Meersseman, Wouter ^a   Lagrou, Katrien ^a   Maertens, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTICAL DENSITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84858602013     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06423-11     Document Type: Article

References (33)

1. Agrawal S, Hope W, Sinkó J, Kibbler C. 2011. Optimizing management of invasive mould diseases. J. Antimicrob. Chemother. 66(Suppl 1):i45-i53.
2. Becker MJ, et al. 2003. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 121:448-457. (Pubitemid 36628336)
3. Bergeron A, et al. 2010. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137:410-415.
4. Clancy CJ, et al. 2007. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J. Clin. Microbiol. 45:1759-1765. (Pubitemid 46933903)
5. Cuenca-Estrella M, et al. 2011. Detection and investigation of invasive mould disease. J. Antimicrob. Chemother. 66(Suppl 1):i15-i24.
6. De Pauw B, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
7. Desai R, Ross LA, Hoffman JA. 2009. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr. Infect. Dis. J. 28:283-286.
8. Francesconi A, et al. 2006. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J. Clin. Microbiol. 44: 2475-2480. (Pubitemid 44092414)
9. Greene RE, et al. 2007. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin. Infect. Dis. 44: 373-379. (Pubitemid 46147619)
10. Guo YL, et al. 2010. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 138:817-824.
11. Hage CA, Reynolds JM, Durkin M, Wheat LJ, Knox KS. 2007. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J. Clin. Microbiol. 45:676-677.
12. Hope WW, Walsh TJ, Denning DW. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5:609-622. (Pubitemid 41383906)
13. Hsu LY, et al. 2010. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect. Dis. 10:44.
14. Husain S, et al. 2008. Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin. Vaccine Immunol. 15: 1760-1763.
15. Husain S, et al. 2007. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83:1330-1336. (Pubitemid 46800308)
16. Kousha M, Tadi R, Soubani AO. 2011. Pulmonary aspergillosis: a clinical review. Eur. Respir. Rev. 20:156-174.
17. Leeflang MM, et al. 2008. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst. Rev. 4:CD007394.
18. Luong ML, et al. 2011. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin. Infect. Dis. 52:1218-1226.
19. Maertens J, et al. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688-1693.
20. Maschmeyer G, et al. 2009. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur. J. Cancer. 45:2462-2472.
21. Meersseman W, et al. 2008. Galactomannan in bronchoalveolar lavage fluid. A tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177:27-34.
22. Musher B, et al. 2004. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42:5517-5522. (Pubitemid 39664330)
23. Nguyen MH, et al. 2007. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmuno-compromised hosts. J. Clin. Microbiol. 45:2787-2792. (Pubitemid 47417315)
24. Nguyen MH, et al. 2011. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol. Blood Marrow Transplant. 17:1043-1050.
25. Nucci M, et al. 2010. Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin. Infect. Dis. 51: 1273-1280.
26. Park SY, et al. 2010. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J. Infect. 61:492-498.
27. Pasqualotto AC, et al. 2010. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation 90:306-311.
28. Racil Z, et al. 2011. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. Int. J. Infect. Dis. 15:e874-e881.
29. Ramos ER, et al. 2011. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 16:1049-1060.
30. Sanguinetti M, et al. 2003. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J. Clin. Microbiol. 41:3922-3925. (Pubitemid 36994742)
31. Sherif R, Segal BH. 2010. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr. Opin. Pulm. Med. 16:242-250.
32. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr MA. 2007. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin. Infect. Dis. 44:531-540. (Pubitemid 46233255)
33. Walsh TJ, et al. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46: 327-360. (Pubitemid 351265310)